You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 160 No. 15, August 14, 2000 TABLE OF CONTENTS
  Archives
  •  Online Features
  Clinical Observation
 This Article
 •Full text
 •PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on ISI (15)
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Topic Collections
 •HIV/AIDS
 •Alert me on articles by topic

Report of a False-Positive HIV Test Result and the Potential Use of Additional Tests in Establishing HIV Serostatus

Eleftherios Mylonakis, MD; Maria Paliou, MD; Thomas C. Greenbough, MD; Timothy P. Flaningan, MD; Norman L. Letvin, MD; Josiah D. Rich, MD, MPH

Arch Intern Med. 2000;160:2386-2388.

Considering the lifelong implications of a positive human immunodeficiency virus (HIV) test result, physicians should be aware of the limitations of tests for HIV. A 43-year-old man had a reactive enzyme-linked immunosorbent assay and an indeterminate result on Western blot analysis. The results of subsequent enzyme-linked immunosorbent assay and Western blot tests were interpreted as positive, and the patient was informed that he had HIV infection. Persistently undetectable plasma HIV-1 RNA, combined with normal physical examination findings, CD4+ cell count, and CD4/CD8 ratio, prompted further testing, which revealed that the patient was not infected with HIV. False-positive HIV test results are uncommon, but they can occur. In the appropriate clinical setting, follow-up and the use of other laboratory tests, such as determination of plasma viral load, may help identify such cases.


From the Infectious Disease Division, Massachusetts General and Brigham and Women's Hospitals (Dr Mylonakis), and the Department of Medicine, Beth Israel Deaconess Medical Center (Dr Letvin), Harvard Medical School, Boston; the Department of Medicine, Division of Clinical Immunology, The Miriam Hospital, Brown University School of Medicine, Providence, RI (Drs Mylonakis, Paliou, Flaningan, and Rich); and the Program in Molecular Medicine, Department of Pediatrics, University of Massachusetts Medical School, Worcester (Dr Greenbough).



THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Screening for HIV: A Review of the Evidence for the U.S. Preventive Services Task Force
Chou et al.
ANN INTERN MED 2005;143:55-73.
ABSTRACT | FULL TEXT  

Two "HIV-Infected" Persons Not Really Infected
Wood et al.
Arch Intern Med 2003;163:1857-1859.
FULL TEXT  

Indeterminate Human Immunodeficiency Virus Western Blot Profiles in Ethiopians with Discordant Screening-Assay Results
Meles et al.
CVI 2002;9:160-163.
ABSTRACT | FULL TEXT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2000 American Medical Association. All Rights Reserved.